Atlas Trials

Study of [11C]CPPC as a Clinical PET Radioligand Biomarker of Microglial Activation in ALS

Clinical trial NCT05602142 · NOT_YET_RECRUITING

Trial details

NCT number
NCT05602142
Sponsor
Johns Hopkins University
Status
NOT_YET_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
ALS
Start date
2026-08-01
Primary completion
2027-01-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.